Co-administration of albumin-furosemide in patients with the nephrotic syndrome

Generalized edema is one of the most important complications in patients with nephrotic syndrome. Diuretics like furosemide are the first choice for reducing the edema. Hypo-albuminemia reduces the effect of furosemide, and thus, this drug is co-administered with albumin to reinforce the therapeutic...

Full description

Bibliographic Details
Main Authors: Ali Ghafari, Alireza Mehdizadeh, Ilad Alavi-Darazam, Ezatollah Rahimi, Catauon Kargar, Nariman Sepehrvand
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=3;spage=471;epage=475;aulast=Ghafari
_version_ 1819226866228133888
author Ali Ghafari
Alireza Mehdizadeh
Ilad Alavi-Darazam
Ezatollah Rahimi
Catauon Kargar
Nariman Sepehrvand
author_facet Ali Ghafari
Alireza Mehdizadeh
Ilad Alavi-Darazam
Ezatollah Rahimi
Catauon Kargar
Nariman Sepehrvand
author_sort Ali Ghafari
collection DOAJ
description Generalized edema is one of the most important complications in patients with nephrotic syndrome. Diuretics like furosemide are the first choice for reducing the edema. Hypo-albuminemia reduces the effect of furosemide, and thus, this drug is co-administered with albumin to reinforce the therapeutic effect and for the correction of reduced oncotic pressure. The aim of this study was to compare urine volume and 24-hour sodium levels after using furosemide alone versus using furosemide along with albumin in patients with nephrotic syndrome. In a randomized clinical trial, ten patients with nephrotic syndrome were chosen and were randomly allocated into four groups. Three therapeutic protocols were chosen, and at the end, each patient had received all three protocols randomly. Data were gathered and analyzed using non-parametric tests in SPSS software. The average urine volume after receiving albumin alone, furosemide alone and albumin plus furosemide were 742 mL (SD = 528), 1707 mL (SD = 745) and 2175 mL (SD = 971), respectively (P = 0.015); the fractional excretion of sodium was 1.96 (SD = 0.251), 3.18 (SD = 0.25), and 4.77 (SD = 8.45), respectively (P = 0.000); the 24-hour urinary sodium levels were 18.3 (SD = 6.68), 208.4 (SD = 5.27) and 206 (SD = 8.45), respectively; while the glomerular filtration rate (GFR) was 104.5, 96.6 and 106.6 (P = 0.021), respectively, in the three therapy groups. Our study shows that albumin administration alone and with furosemide in patients with nephrotic syndrome who had normal kidney function, results in different urine volumes and sodium levels. Co-administration of albumin and furosemide increased the urine volume and sodium level, which is due to increase in the GFR as well as the diuretic effects of furosemide.
first_indexed 2024-12-23T10:32:18Z
format Article
id doaj.art-6c353c6dbc8a45c487949cd02c4a3fcf
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-12-23T10:32:18Z
publishDate 2011-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-6c353c6dbc8a45c487949cd02c4a3fcf2022-12-21T17:50:24ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422011-01-01223471475Co-administration of albumin-furosemide in patients with the nephrotic syndromeAli GhafariAlireza MehdizadehIlad Alavi-DarazamEzatollah RahimiCatauon KargarNariman SepehrvandGeneralized edema is one of the most important complications in patients with nephrotic syndrome. Diuretics like furosemide are the first choice for reducing the edema. Hypo-albuminemia reduces the effect of furosemide, and thus, this drug is co-administered with albumin to reinforce the therapeutic effect and for the correction of reduced oncotic pressure. The aim of this study was to compare urine volume and 24-hour sodium levels after using furosemide alone versus using furosemide along with albumin in patients with nephrotic syndrome. In a randomized clinical trial, ten patients with nephrotic syndrome were chosen and were randomly allocated into four groups. Three therapeutic protocols were chosen, and at the end, each patient had received all three protocols randomly. Data were gathered and analyzed using non-parametric tests in SPSS software. The average urine volume after receiving albumin alone, furosemide alone and albumin plus furosemide were 742 mL (SD = 528), 1707 mL (SD = 745) and 2175 mL (SD = 971), respectively (P = 0.015); the fractional excretion of sodium was 1.96 (SD = 0.251), 3.18 (SD = 0.25), and 4.77 (SD = 8.45), respectively (P = 0.000); the 24-hour urinary sodium levels were 18.3 (SD = 6.68), 208.4 (SD = 5.27) and 206 (SD = 8.45), respectively; while the glomerular filtration rate (GFR) was 104.5, 96.6 and 106.6 (P = 0.021), respectively, in the three therapy groups. Our study shows that albumin administration alone and with furosemide in patients with nephrotic syndrome who had normal kidney function, results in different urine volumes and sodium levels. Co-administration of albumin and furosemide increased the urine volume and sodium level, which is due to increase in the GFR as well as the diuretic effects of furosemide.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=3;spage=471;epage=475;aulast=Ghafari
spellingShingle Ali Ghafari
Alireza Mehdizadeh
Ilad Alavi-Darazam
Ezatollah Rahimi
Catauon Kargar
Nariman Sepehrvand
Co-administration of albumin-furosemide in patients with the nephrotic syndrome
Saudi Journal of Kidney Diseases and Transplantation
title Co-administration of albumin-furosemide in patients with the nephrotic syndrome
title_full Co-administration of albumin-furosemide in patients with the nephrotic syndrome
title_fullStr Co-administration of albumin-furosemide in patients with the nephrotic syndrome
title_full_unstemmed Co-administration of albumin-furosemide in patients with the nephrotic syndrome
title_short Co-administration of albumin-furosemide in patients with the nephrotic syndrome
title_sort co administration of albumin furosemide in patients with the nephrotic syndrome
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2011;volume=22;issue=3;spage=471;epage=475;aulast=Ghafari
work_keys_str_mv AT alighafari coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome
AT alirezamehdizadeh coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome
AT iladalavidarazam coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome
AT ezatollahrahimi coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome
AT catauonkargar coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome
AT narimansepehrvand coadministrationofalbuminfurosemideinpatientswiththenephroticsyndrome